BridgeMD
New treatment option for Myasthenia Gravis, Generalized
Official title Study of Aritinercept in Patients With Generalized Myasthenia Gravis
ClinicalTrials.gov ID: NCT07596901
What this study is testing
What is Aritinercept?
Aritinercept is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for myasthenia gravis, generalized.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This clinical study will enroll patients with generalized myasthenia gravis (gMG). The goal of this clinical study is to assess the safety, tolerability, effectiveness, pharmacokinetics (how the body processes the drug) and pharmacodynamics (how the drug affects the body) of aritinercept.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Adult patients (18-85 years old)
- Myasthenia Gravis Foundation of America (MGFA) Class II-IV gMG
- Additional are defined in the protocol Key
You likely can't join if
- Current or medical history of malignancy within the last 5 years
- Pregnant, breastfeeding or intending to become pregnant during the Study
- Additional exclusion criteria are defined in the protocol
The study team makes the final eligibility decision.
Where it's taking place
- Altamonte Springs, Florida, United States
- Boca Raton, Florida, United States
- Miami, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Altamonte Springs, Florida, United States; Boca Raton, Florida, United States; Miami, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.